The European Strategy Forum on Research Infrastructures (ESFRI) roadmap has just been updated, with six new research infrastructures added. The ESFRI roadmap was set up to support a coherent and strategy-led approach to policy-making on research infrastructures. The six new research infrastructures that have been added are considered to have a major importance for the research landscape in the EU. Once on the ESFRI roadmap, partners will work towards securing national funding in order to construct and operate them.
Three of the infrastructures are in the bio and medical sciences (BMS) field and three in energy. In the energy field, EU-SOLARIS is the European SOLAR Research Infrastructure for Concentrating Solar Power, MYRRHA is the Multipurpose hybrid Research Reactor for High-technology Applications and Windscanner is the European Wind Scanner Facility. In the BMS field, ANAEE is the Infrastructure for Analysis and Experimentation on Ecosystems, ISBE is the Infrastructure for Systems Biology-Europe and MIRRI is the Microbial Resource Research Infrastructure. The updated roadmap also provides a report on the implementation of and the progress made by the other ESFRI Research Infrastructures.











Geography and Environmental Studies academics – would you like to get more involved in preparing our next REF submission?
Reminder: Recharge Your Research Routine Next Week for World Wellbeing Week
Boost Your Research Toolkit: Digital Confidence & AI Literacy Workshop – Friday 26 June 10am-12pm
BU students’ publishing success
BU presentation at the University of Bristol
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease